|
|
| Phases of Development | Preclinical | Pilot | Phase II | Phase III | Registration | Approved | Marketed |
|---|
| Cancer | 2 | 0 | 0 | 1 | 0 | 0 | 5 | | Cardiovascular | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Diagnostic | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Endocrine / Metabolic | 0 | 0 | 4 | 2 | 2 | 1 | 13 | | Musculoskeletal | 0 | 1 | 1 | 0 | 0 | 1 | 9 | | Neurology | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Estrogen receptor